**Question:** Substrate level phosphorylation in glycolysis is seen in

A. Pyruvate kinase
B. Enolase
C. Alcohol dehydrogenase
D. Glyceraldehyde-3-phosphate dehydrogenase

**Correct Answer:** D. Glyceraldehyde-3-phosphate dehydrogenase

**Core Concept:** Substrate-level phosphorylation is a type of energy coupling process that occurs during cellular respiration, where ADP is converted to ATP directly at the site of enzyme action on its substrate. In this process, the enzyme uses the energy from the binding of substrate to change its conformation, which results in the release of energy to phosphorylate a molecule.

**Why the Correct Answer is Right:** Glycolysis is a key process in cellular energy production, where glucose is broken down into pyruvate. Substrate-level phosphorylation is a crucial aspect of glycolysis, occurring in the final step of this process. Among the given options, D. Glyceraldehyde-3-phosphate dehydrogenase is the enzyme responsible for catalyzing the conversion of glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate, resulting in the production of 1 molecule of ATP.

**Why Each Wrong Option is Incorrect:**

A. Pyruvate kinase (Option A) is an enzyme involved in the final step of glycolysis, catalyzing the conversion of phosphoenolpyruvate to pyruvate. However, pyruvate kinase does not participate in substrate-level phosphorylation.

B. Enolase (Option B) is involved in the second step of glycolysis, catalyzing the conversion of 2-phosphoglycerate to phosphoenolpyruvate. Enolase does not catalyze substrate-level phosphorylation.

C. Alcohol dehydrogenase (Option C) is an enzyme involved in the process of alcohol oxidation. It does not play a role in substrate-level phosphorylation during glycolysis.

**Clinical Pearl:** Understanding substrate-level phosphorylation is essential for medical students, as it directly impacts their understanding of cellular energy production and the overall efficiency of energy supply in the body. This knowledge is crucial for diagnosing and treating various clinical conditions related to energy production, such as in tissues with impaired glucose utilization (e.g., in sepsis) and understanding drug effects on glycolysis (e.g., understanding the effect of fructose-2,6-bisphosphatase inhibitors in diabetes therapy).